Quick answers
- Is CVE-2026-93936 exploited in the wild?
- No. Junglewise Threat Intelligence has no report of CVE-2026-93936 being exploited in the wild.
- How severe is CVE-2026-93936?
- Critical severity, with a CVSS score of 9.8, published 10 October 2026.
- Which products and versions are affected?
- ThemeREX Group IPharm through 1.2.4.
- Is there a fix for CVE-2026-93936?
- No fixed version is recorded yet. Patchstack has issued a mitigation rule to block attacks until an official patch is available; apply this rule immediately if using the affected theme. If you run it, Junglewise drafts a mitigation that fits your setup and applies it once you approve, with senior security engineers behind it.
- How is CVE-2026-93936 attacked?
- It is attacked over the network, in a web application.
- Am I affected by CVE-2026-93936?
- Check whether you run ThemeREX Group IPharm at an affected version. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.
How to fix
Patchstack has issued a mitigation rule to block attacks until an official patch is available; apply this rule immediately if using the affected theme.
Technical details
The vulnerability is a PHP object injection (deserialization of untrusted data) in the IPharm WordPress theme affecting versions through 1.2.4. An unauthenticated attacker can inject malicious serialized objects to trigger arbitrary code execution on the server. No official patch is currently available.
Affected products
- ThemeREX Group IPharm through 1.2.4
Timeline
- 2026-10-10: disclosed
- 2026-02-28: other: Reported to Patchstack